Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 10

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The molecular identity of the TLQP-21 peptide receptor

Sahu, Bhavani S., Nguyen, Megin E., Rodriguez, Pedro, Pallais, Jean Pierre, Ghosh, Vinayak, Razzoli, Maria, Sham, Yuk Y., Salton, Stephen R., Bartolomucci, Alessandro · 2021 · Cellular and Molecular Life Sciences

Abstract

The TLQP-21 neuropeptide has been implicated in functions as diverse as lipolysis, neurodegeneration and metabolism, thus suggesting an important role in several human diseases. Three binding targets have been proposed for TLQP-21: C3aR1, gC1qR and HSPA8. The aim of this review is to critically evaluate the molecular identity of the TLQP-21 receptor and the proposed multi-receptor mechanism of action. Several studies confirm a critical role for C3aR1 in TLQP-21 biological activity and a largely conserved mode of binding, receptor activation and signaling with C3a, its first-identified endogenous ligand. Conversely, data supporting a role of gC1qR and HSPA8 in TLQP-21 activity remain limited, with no signal transduction pathways being described. Overall, C3aR1 is the only receptor for which a necessary and sufficient role in TLQP-21 activity has been confirmed thus far. This conclusion calls into question the validity of a multi-receptor mechanism of action for TLQP-21 and should inform future studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00018-021-03944-1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 75

  1. Bartolomucci A, Possenti R, Mahata SK et al (2011) The extended granin family: structure, function, and biomedical implications. Endocr Rev 32:755–797. https://doi.org/10.1210/er.2010-0027 · DOI · Paper page
  2. Levi A, Ferri GL, Watson E et al (2004) Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor. Cell Mol Neurobiol 24:517–533 · DOI
  3. Bartolomucci A, La Corte G, Possenti R et al (2006) TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc Natl Acad Sci USA 103:14584–14589. https://doi.org/10.1073/pnas.0606102103 · DOI · Paper page
  4. Sahu BSBS, Rodriguez P, Nguyen MEME et al (2019) Peptide/receptor co-evolution explains the lipolytic function of the neuropeptide TLQP-21. Cell Rep 28:2567-2580.e6. https://doi.org/10.1016/j.celrep.2019.07.101 · DOI · Paper page
  5. Possenti R, Muccioli G, Petrocchi P et al (2012) Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21. Biochem J 441:511–522. https://doi.org/10.1042/BJ20111165 · doi:10.1042/bj20111165
  6. Fairbanks CA, Peterson CD, Speltz RH et al (2014) The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity. Pain 155:1229–1237. https://doi.org/10.1016/j.pain.2014.03.012 · DOI
  7. Doolen S, Cook J, Riedl M et al (2017) Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling. Glia 65:1976–1989. https://doi.org/10.1002/glia.23208 · DOI · Paper page
  8. Lewis JE, Brameld JM, Hill P et al (2017) Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain. PLoS One 12:e0172724. https://doi.org/10.1371/journal.pone.0172724 · DOI
  9. Stephens SB, Schisler JC, Hohmeier HE et al (2012) A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function. Cell Metab 16:33–43. https://doi.org/10.1016/j.cmet.2012.05.011 · doi:10.1016/j.cmet.2012.05.011
  10. Severini C, La Corte G, Improta G et al (2009) In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions. Br J Pharmacol 157:984–993. https://doi.org/10.1111/j.1476-5381.2009.00192.x · doi:10.1111/j.1476-5381.2009.00192.x
  11. Hannedouche S, Beck V, Leighton-Davies J et al (2013) Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells. J Biol Chem 288:27434–27443. https://doi.org/10.1074/jbc.M113.497214 · DOI
  12. Chen Y-C, Pristerá A, Ayub M et al (2013) Identification of a receptor for neuropeptide VGF and its role in neuropathic pain. J Biol Chem 288:34638–34646. https://doi.org/10.1074/jbc.M113.510917 · DOI
  13. Akhter S, Chakraborty S, Moutinho D et al (2017) The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa protein 8 (HSPA8)on the surface of SH-SY5Y cells. PLoS ONE 12:e0185176. https://doi.org/10.1371/journal.pone.0185176 · DOI
  14. Petrocchi-Passeri P, Cero C, Cutarelli A et al (2015) The VGF-derived peptide TLQP-62 modulates insulin secretion and glucose homeostasis. J Mol Endocrinol 54:227–239. https://doi.org/10.1530/JME-14-0313 · doi:10.1530/jme-14-0313
  15. Cero C, Vostrikov VV, Verardi R et al (2014) The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism. Structure 22:1744–1753. https://doi.org/10.1016/j.str.2014.10.001 · doi:10.1016/j.str.2014.10.001
  16. D’Amato F, Noli B, Angioni L et al (2015) VGF peptide profiles in type 2 diabetic patients’ plasma and in obese mice. PLoS One. https://doi.org/10.1371/journal.pone.0142333 · DOI
  17. Brancia C, Noli B, Boido M et al (2016) VGF protein and Its C-terminal derived peptides in amyotrophic lateral sclerosis: human and animal model studies. PLoS One 11:e0164689. https://doi.org/10.1371/journal.pone.0164689 · DOI
  18. Lisci C, Lewis JE, Daniel ZCTR et al (2019) Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21. PLoS One. https://doi.org/10.1371/journal.pone.0221517 · DOI
  19. S N, O K, R ASC (2019) VGF: a biomarker and potential target for the treatment of neuropathic pain? Pain Rep. https://doi.org/10.1097/PR9.0000000000000786 · DOI
  20. Lin W-J, Jiang C, Sadahiro M et al (2015) VGF and its C-terminal peptide TLQP-62 regulate memory formation in hippocampus via a BDNF-TrkB-dependent mechanism. J Neurosci 35:10343–10356. https://doi.org/10.1523/JNEUROSCI.0584-15.2015 · DOI
  21. Jiang C, Lin WJ, Labonté B et al (2019) VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine. Neuropsychopharmacology 44:971–981. https://doi.org/10.1038/s41386-018-0277-4 · DOI · Paper page
  22. Dalbøge LS, Jacobsen JM, Mehrotra S et al (2020) Evaluation of VGF peptides as potential anti-obesity candidates in pre-clinical animal models. Peptides. https://doi.org/10.1016/j.peptides.2020.170444 · DOI
  23. Molteni L, Rizzi L, Bresciani E et al (2017) Pharmacological and biochemical characterization of TLQP-21 activation of a binding site on CHO cells. Front Pharmacol 8:167. https://doi.org/10.3389/fphar.2017.00167 · DOI
  24. Severini C, Ciotti MT, Biondini L et al (2008) TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation. J Neurochem 104:534–544. https://doi.org/10.1111/j.1471-4159.2007.05068.x · DOI
  25. Cassina V, Torsello A, Tempestini A et al (2013) Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity. Biochim Biophys Acta 1828:455–460. https://doi.org/10.1016/j.bbamem.2012.10.023 · doi:10.1016/j.bbamem.2012.10.023
  26. Petrocchi Passeri P, Biondini L, Mongiardi MP et al (2013) Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line. Neuroendocrinology 97:212–224. https://doi.org/10.1159/000339855 · doi:10.1159/000339855
  27. Cero C, Razzoli M, Han R et al (2017) The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis. Mol Metab 6:148–158. https://doi.org/10.1016/j.molmet.2016.10.005 · DOI · Paper page
  28. Elmadany N, de Almeida SF, Wendt S et al (2020) The VGF-derived peptide TLQP21 impairs purinergic control of chemotaxis and phagocytosis in mouse microglia. J Neurosci 40:3320–3331. https://doi.org/10.1523/JNEUROSCI.1458-19.2020 · DOI · Paper page
  29. Cho K, Jang YJ, Lee SJ et al (2020) TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β. Biochem Biophys Res Commun 524:764–771. https://doi.org/10.1016/j.bbrc.2020.01.111 · DOI
  30. Jethwa PH, Warner A, Nilaweera KN et al (2007) VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters. Endocrinology 148:4044–4055. https://doi.org/10.1210/en.2007-0038 · doi:10.1210/en.2007-0038
  31. Stephens SB, Edwards RJ, Sadahiro M et al (2017) The prohormone VGF regulates β cell function via insulin secretory granule biogenesis. Cell Rep 20:2480–2489. https://doi.org/10.1016/j.celrep.2017.08.050 · doi:10.1016/j.celrep.2017.08.050
  32. Rizzi R, Bartolomucci A, Moles A et al (2008) The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain. Neurosci Lett. https://doi.org/10.1016/j.neulet.2008.06.018 · DOI
  33. Pinilla L, Pineda R, Gaytán F et al (2011) Characterization of the reproductive effects of the anorexigenic VGF-derived peptide TLQP-21: in vivo and in vitro studies in male rats. Am J Physiol Endocrinol Metab 300:E837–E847. https://doi.org/10.1152/ajpendo.00598.2010 · DOI
  34. Razzoli M, Bo E, Pascucci T et al (2012) Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses. Behav Brain Res. https://doi.org/10.1016/j.bbr.2012.01.038 · DOI
  35. Jiang C, Lin WJ, Sadahiro M et al (2018) VGF function in depression and antidepressant efficacy. Mol Psychiatry 23:1632–1642. https://doi.org/10.1038/mp.2017.233 · DOI
  36. Bartolomucci A, Possenti R, Levi A et al (2007) The role of the vgf gene and VGF-derived peptides in nutrition and metabolism. Genes Nutr. https://doi.org/10.1007/s12263-007-0047-0 · DOI
  37. Bresciani E, Possenti R, Coco S et al (2020) TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: focus on in vitro calcium signaling. Int J Mol Sci 21:130 · DOI
  38. Bartolomucci A, Moles A, Levi A, Possenti R (2008) Pathophysiological role of TLQP-21: gastrointestinal and metabolic functions. Eat Weight Disord 13:e49
  39. Bartolomucci A, Bresciani E, Bulgarelli I et al (2009) Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice. Genes Nutr. https://doi.org/10.1007/s12263-009-0110-0 · DOI
  40. Chassaing B, Koren O, Goodrich JK et al (2015) Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519:92–96. https://doi.org/10.1038/nature14232 · DOI · Paper page
  41. Weiszhár Z, Czúcz J, Révész C et al (2012) Complement activation by polyethoxylated pharmaceutical surfactants: cremophor-EL, tween-80 and tween-20. Eur J Pharm Sci 45:492–498 · DOI · Paper page
  42. Liu Z, Qiu S, Liu Z et al (2013) Complement activation associated with polysorbate 80 in beagle dogs. Int Immunopharmacol 15:144–149. https://doi.org/10.1016/j.intimp.2012.10.021 · DOI
  43. Riedl MS, Braun PD, Kitto KF et al (2009) Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing. J Neurosci 29:13377–13388. https://doi.org/10.1523/JNEUROSCI.1127-09.2009 · DOI
  44. Turolla EA, Valtorta S, Bresciani E et al (2018) Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled analog prepared via [18F]aluminum fluoride chelation chemistry. Front Pharmacol 9:1274. https://doi.org/10.3389/fphar.2018.01274 · DOI
  45. Hollmann TJ, Haviland DL, Kildsgaard J et al (1998) Cloning, expression, sequence determination, and chromosome localization of the mouse complement C3a anaphylatoxin receptor gene. Mol Immunol 35:137–148 · DOI
  46. Quell KM, Karsten CM, Kordowski A et al (2017) Monitoring C3aR expression using a Floxed tdTomato-C3aR reporter knock-in mouse. J Immunol 199:688–706. https://doi.org/10.4049/jimmunol.1700318 · DOI · Paper page
  47. Mamane Y, Chung Chan C, Lavallee G et al (2009) The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes 58:2006–2017. https://doi.org/10.2337/db09-0323 · DOI · Paper page
  48. Klos A, Wende E, Wareham KJ, Monk PN (2013) International union of basic and clinical pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol Rev 65:500–543 · DOI · Paper page
  49. Sun J, Ember JA, Chao TH et al (1999) Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor. Protein Sci 8:2304–2311. https://doi.org/10.1110/ps.8.11.2304 · DOI
  50. Vibhuti A, Gupta K, Subramanian H et al (2011) Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells. PLoS One 6:e19585. https://doi.org/10.1371/journal.pone.0019585 · doi:10.1371/journal.pone.0019585
  51. Lim J, Iyer A, Suen JY et al (2013) C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J 27:822–831. https://doi.org/10.1096/fj.12-220582 · DOI · Paper page
  52. Razzoli M, Frontini A, Gurney A et al (2016) Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis. Mol Metab 5:19–33. https://doi.org/10.1016/j.molmet.2015.10.005 · DOI
  53. Mathieu MC, Sawyer N, Greig GM et al (2005) The C3a receptor antagonist SB 290157 has agonist activity. Immunol Lett 100:139–145. https://doi.org/10.1016/j.imlet.2005.03.003 · DOI
  54. Li K, Anderson KJ, Peng Q et al (2008) Cyclic AMP plays a critical role in C3a-receptor mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112:5084–5094. https://doi.org/10.1182/blood-2008-05-156646 · DOI
  55. Robertson N, Rappas M, Doré AS et al (2018) Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727. Nature 553:111–114. https://doi.org/10.1038/nature25025 · DOI
  56. Reid RC, Yau M-K, Singh R et al (2013) Downsizing a human inflammatory protein to a small molecule with equal potency and functionality. Nat Commun 4:2802. https://doi.org/10.1038/ncomms3802 · doi:10.1038/ncomms3802
  57. Rowley JA, Reid RC, Poon EKY et al (2020) Potent thiophene antagonists of human complement C3a receptor with anti-inflammatory activity. J Med Chem 63:529–541. https://doi.org/10.1021/acs.jmedchem.9b00927 · DOI
  58. Coulthard LG, Woodruff TM (2015) Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth. J Immunol 194:3542–3548. https://doi.org/10.4049/jimmunol.1403068 · DOI · Paper page
  59. Hugli TE, Müller-Eberhard HJ (1978) Anaphylatoxins: C3a and C5a. Adv Immunol 26:1–53 · DOI · Paper page
  60. Housden BE, Muhar M, Gemberling M et al (2016) Loss-of-function genetic tools for animal models: cross-species and cross-platform differences. Nat Rev Genet 181(18):24–40. https://doi.org/10.1038/nrg.2016.118 · DOI · Paper page
  61. Fargali S, Garcia AL, Sadahiro M et al (2014) The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure. FASEB J 28:2120–2133. https://doi.org/10.1096/fj.13-239509 · doi:10.1096/fj.13-239509
  62. Ames RS, Lee D, Foley JJ et al (2001) Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory Activity in animal models. J Immunol 166:6341–6348. https://doi.org/10.4049/jimmunol.166.10.6341 · DOI · Paper page
  63. Li XX, Kumar V, Clark RJ et al (2021) The “C3aR Antagonist” SB290157 is a partial C5aR2 agonist. Front Pharmacol 11:2241. https://doi.org/10.3389/fphar.2020.591398 · DOI
  64. Molteni L, Rizzi L, Bresciani E et al (2017) Pharmacological and biochemical characterization of TLQP-21 activation of a binding site on CHO cells. Front Pharmacol. https://doi.org/10.3389/fphar.2017.00167 · DOI
  65. Ghebrehiwet B, Geisbrecht BV, Xu X et al (2019) The C1q receptors: focus on gC1qR/p33 (C1qBP, p32, HABP-1)1. Semin Immunol 45:101338 · DOI
  66. Ghebrehiwet B, Lim BL, Peerschke EIB et al (1994) Isolation, cdna clonlng, and overexpression of a 33-kd cell surface glycoprotein that binds to the globular “heads” of clq. J Exp Med 179:1809–1821. https://doi.org/10.1084/jem.179.6.1809 · DOI · Paper page
  67. Peterson KL, Zhang W, Lu PD et al (1997) The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization. Clin Immunol Immunopathol 84:17–26. https://doi.org/10.1006/clin.1997.4374 · doi:10.1006/clin.1997.4374
  68. Kouser L, Madhukaran SP, Shastri A et al (2015) Emerging and novel functions of complement protein C1q. Front Immunol 6:317 · DOI · Paper page
  69. Ugurlar D, Howes SC, De Kreuk BJ et al (2018) Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement. Science (-80) 359:794–797. https://doi.org/10.1126/science.aao4988 · DOI · Paper page
  70. Stricher F, Macri C, Ruff M, Muller S (2013) HSPA8/HSC70 chaperone protein: Structure, function, and chemical targeting. Autophagy 9:1937–1954 · DOI · Paper page
  71. Bonam SR, Ruff M, Muller S (2019) HSPA8/HSC70 in immune disorders: a molecular rheostat that adjusts chaperone-mediated autophagy substrates. Cells 8:849 · DOI
  72. Kettner S, Kalthoff F, Graf P et al (2007) EWI-2/CD316 is an inducible receptor of HSPA8 on human dendritic cells. Mol Cell Biol 27:7718–7726. https://doi.org/10.1128/mcb.00180-07 · DOI
  73. B G, Y L, K A, A GR (2013) Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg. Protein Sci 22:204–212. https://doi.org/10.1002/PRO.2200 · DOI
  74. Z P, L JI, M ME et al (2014) Crystal structure of the stress-inducible human heat shock protein 70 substrate-binding domain in complex with peptide substrate. PLoS One. https://doi.org/10.1371/JOURNAL.PONE.0103518 · DOI
  75. K BG, S A, M KR et al (2020) Factor XII and kininogen asymmetric assembly with gC1qR/C1QBP/P32 is governed by allostery. Blood 136:1685–1697. https://doi.org/10.1182/BLOOD.2020004818 · DOI

Cited by

See all 10

Metadata

Authors
Sahu, B. S., Nguyen, M. E., Rodriguez, P., Pallais, J. P., Ghosh, V., Razzoli, M., Sham, Y. Y., Salton, S. R., & Bartolomucci, A.
Venue
Cellular and Molecular Life Sciences
Published
2021-10-09
Volume
78
Issue
23
Pages
7133-7144
ISSN
  • 1420-682X
  • 1420-9071
Cited by
10
References
5
Language
en
Licence
Funders
national institutes of health (DK117504, DK118150, DK102496, AG062355, AG062661)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The molecular identity of the TLQP-21 peptide receptor. https://app.cochat.ai/papers/10.1007/s00018-021-03944-1
The paper
Sahu, B. S., Nguyen, M. E., Rodriguez, P., Pallais, J. P., Ghosh, V., Razzoli, M., Sham, Y. Y., Salton, S. R., & Bartolomucci, A. (2021). The molecular identity of the TLQP-21 peptide receptor. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-021-03944-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.